Tyrosine kinase inhibitor discontinuation in non-allografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study
Not available.
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-01-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11897 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841550898299404288 |
|---|---|
| author | Matteo Dragani Michela Ansuinelli Cristina Papayannidis Nicola Fracchiolla Valeria Cardinali Michele Cedrone Fabio Guolo Salvatore Perrone Prassede Salutari Elisabetta Todisco Robin Foà Sabina Chiaretti |
| author_facet | Matteo Dragani Michela Ansuinelli Cristina Papayannidis Nicola Fracchiolla Valeria Cardinali Michele Cedrone Fabio Guolo Salvatore Perrone Prassede Salutari Elisabetta Todisco Robin Foà Sabina Chiaretti |
| author_sort | Matteo Dragani |
| collection | DOAJ |
| description |
Not available.
|
| format | Article |
| id | doaj-art-261cf834dc3a4d52985b429c9a1e0b39 |
| institution | Kabale University |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| series | Haematologica |
| spelling | doaj-art-261cf834dc3a4d52985b429c9a1e0b392025-01-09T19:43:51ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-01-01999110.3324/haematol.2024.286325Tyrosine kinase inhibitor discontinuation in non-allografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life studyMatteo Dragani0Michela Ansuinelli1Cristina Papayannidis2Nicola Fracchiolla3Valeria Cardinali4Michele Cedrone5Fabio Guolo6Salvatore Perrone7Prassede Salutari8Elisabetta Todisco9Robin Foà10Sabina Chiaretti11Hematology and Cellular Therapy, IRCCS Ospedale Policlinico San MartinoHematology, Department of Translational and Precision Medicine, Sapienza University of RomeIstituto di Ematologia “Seràgnoli”, IRCCS Azienda Ospedaliero-Universitaria di BolognaHematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, MilanoDipartimento di Medicina e Chirurgia, Università di Perugia, Ospedale "Santa Maria della Misericordia", PerugiaUOC Ematologia, Azienda Ospedaliera San Giovanni AddolorataClinic of Hematology, Department of Internal Medicine (DiMI), University of GenovaDepartment of Hematology, Polo Universitario Pontino, S.M. Goretti Hospital, LatinaDepartment of Hematology, Ospedale Civile Spirito Santo, PescaraOnco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy; Hematology Division, Busto Arsizio Hospital, ASST Valleolona, VareseHematology, Department of Translational and Precision Medicine, Sapienza University of RomeHematology, Department of Translational and Precision Medicine, Sapienza University of Rome Not available. https://haematologica.org/article/view/11897 |
| spellingShingle | Matteo Dragani Michela Ansuinelli Cristina Papayannidis Nicola Fracchiolla Valeria Cardinali Michele Cedrone Fabio Guolo Salvatore Perrone Prassede Salutari Elisabetta Todisco Robin Foà Sabina Chiaretti Tyrosine kinase inhibitor discontinuation in non-allografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study Haematologica |
| title | Tyrosine kinase inhibitor discontinuation in non-allografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study |
| title_full | Tyrosine kinase inhibitor discontinuation in non-allografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study |
| title_fullStr | Tyrosine kinase inhibitor discontinuation in non-allografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study |
| title_full_unstemmed | Tyrosine kinase inhibitor discontinuation in non-allografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study |
| title_short | Tyrosine kinase inhibitor discontinuation in non-allografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study |
| title_sort | tyrosine kinase inhibitor discontinuation in non allografted philadelphia positive acute lymphoblastic leukemia patients a campus all real life study |
| url | https://haematologica.org/article/view/11897 |
| work_keys_str_mv | AT matteodragani tyrosinekinaseinhibitordiscontinuationinnonallograftedphiladelphiapositiveacutelymphoblasticleukemiapatientsacampusallreallifestudy AT michelaansuinelli tyrosinekinaseinhibitordiscontinuationinnonallograftedphiladelphiapositiveacutelymphoblasticleukemiapatientsacampusallreallifestudy AT cristinapapayannidis tyrosinekinaseinhibitordiscontinuationinnonallograftedphiladelphiapositiveacutelymphoblasticleukemiapatientsacampusallreallifestudy AT nicolafracchiolla tyrosinekinaseinhibitordiscontinuationinnonallograftedphiladelphiapositiveacutelymphoblasticleukemiapatientsacampusallreallifestudy AT valeriacardinali tyrosinekinaseinhibitordiscontinuationinnonallograftedphiladelphiapositiveacutelymphoblasticleukemiapatientsacampusallreallifestudy AT michelecedrone tyrosinekinaseinhibitordiscontinuationinnonallograftedphiladelphiapositiveacutelymphoblasticleukemiapatientsacampusallreallifestudy AT fabioguolo tyrosinekinaseinhibitordiscontinuationinnonallograftedphiladelphiapositiveacutelymphoblasticleukemiapatientsacampusallreallifestudy AT salvatoreperrone tyrosinekinaseinhibitordiscontinuationinnonallograftedphiladelphiapositiveacutelymphoblasticleukemiapatientsacampusallreallifestudy AT prassedesalutari tyrosinekinaseinhibitordiscontinuationinnonallograftedphiladelphiapositiveacutelymphoblasticleukemiapatientsacampusallreallifestudy AT elisabettatodisco tyrosinekinaseinhibitordiscontinuationinnonallograftedphiladelphiapositiveacutelymphoblasticleukemiapatientsacampusallreallifestudy AT robinfoa tyrosinekinaseinhibitordiscontinuationinnonallograftedphiladelphiapositiveacutelymphoblasticleukemiapatientsacampusallreallifestudy AT sabinachiaretti tyrosinekinaseinhibitordiscontinuationinnonallograftedphiladelphiapositiveacutelymphoblasticleukemiapatientsacampusallreallifestudy |